RBC Capital Maintains Outperform on Alkermes, Raises Price Target to $56

Benzinga Newsdesk www.benzinga.com Positive 89.1%

Neg 0% Neu 0% Pos 89.1%

RBC Capital analyst Leonid Timashev maintains Alkermes (NASDAQ:ALKS) with a Outperform and raises the price target from $45 to $56.